Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This is consistent with how these medications work in clinical settings
If more Medicare beneficiaries with obesity or overweight gain access to GLP-1s based on other approved uses for these medications, that could reduce the cost of proposed legislation to lift the statutory prohibition on Medicare coverage of anti-obesity drugs
5 mg/0.5mL
While both are effective, tirzepatide appears to offer more robust outcomes in terms of weight loss and glycaemic control, likely due to its dual mechanism
US$ 22.16
US$ 26.06
US$ 29.53
